dc.creatorBakal, David R.
dc.creatorCoelho, Lara E.
dc.creatorLuz, Paula Mendes
dc.creatorClark, Jesse L.
dc.creatorDe Boni, Raquel Brandini
dc.creatorCardoso, Sandra W.
dc.creatorSantos, Valdiléa Gonçalves Veloso dos
dc.creatorLake, Jordan E.
dc.creatorGrinsztejn, Beatriz
dc.date2018-10-08T15:02:09Z
dc.date2018-10-08T15:02:09Z
dc.date2018
dc.date.accessioned2023-09-26T23:37:30Z
dc.date.available2023-09-26T23:37:30Z
dc.identifierBAKAL, David R. et al. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors. Journal of Antimicrobial Chemotherapy, v. 73, n. 8, p. 2177-2185, 2018.
dc.identifier0305-7453
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/29426
dc.identifier10.1093/jac/dky145
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8892522
dc.descriptionBackground: Obesity rates are increasing among HIV-infected individuals, but risk factors for obesity development on ART remain unclear. Objectives: In a cohort of HIV-infected adults in Rio de Janeiro, Brazil, we aimed to determine obesity rates before and after ART initiation and to analyse risk factors for obesity on ART. Methods: We retrospectively analysed data from individuals initiating ART between 2000 and 2015. BMI was calculated at baseline (time of ART initiation). Participants who were non-obese at baseline and had 90 days of ART exposure were followed until the development of obesity or the end of follow-up. Obesity incidence rates were estimated using Poisson regression models and risk factors were assessed using Cox regression models. Results: Of participants analysed at baseline (n " 1794), 61.3% were male, 48.3% were white and 7.9% were obese. Among participants followed longitudinally (n " 1567), 66.2% primarily used an NNRTI, 32.9% a PI and 0.9% an integrase strand transfer inhibitor (INSTI); 18.3% developed obesity and obesity incidence was 37.4 per 1000 person-years. In multivariable analysis, the greatest risk factor for developing obesity was the use of an INSTI as the primary ART core drug (adjusted HR 7.12, P , 0.0001); other risk factors included younger age, female sex, higher baseline BMI, lower baseline CD4! T lymphocyte count, higher baseline HIV-1 RNA, hypertension and diabetes mellitus. Conclusions: Obesity following ART initiation is frequent among HIV-infected adults. Key risk factors include female sex, HIV disease severity and INSTI use. Further research regarding the association between INSTIs and the development of obesity is needed.
dc.description2028-08-30
dc.formatapplication/pdf
dc.languageeng
dc.rightsrestricted access
dc.subjectObesity
dc.subjectHIV
dc.subjectBody mass index procedure
dc.subjectFollow-up
dc.subjectIntegrase inhibitors
dc.subjectHIV infections
dc.titleObesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors
dc.typeArticle


Este ítem pertenece a la siguiente institución